Entresto Side Effects
Generic name: sacubitril / valsartan
Medically reviewed by Drugs.com. Last updated on Sep 1, 2023.
Note: This document contains side effect information about sacubitril / valsartan. Some dosage forms listed on this page may not apply to the brand name Entresto.
Applies to sacubitril / valsartan: oral tablet.
Warning
Oral route (Tablet)
Drugs that act directly on the renin-angiotensin system may cause fetal injury or death. Discontinue use immediately if pregnancy is detected.
Serious side effects of Entresto
Along with its needed effects, sacubitril/valsartan may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking sacubitril / valsartan:
More common
- Abdominal or stomach pain
- blurred vision
- confusion
- difficult breathing
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- irregular heartbeat
- nausea or vomiting
- nervousness
- numbness or tingling in the hands, feet, or lips
- sweating
- unusual tiredness or weakness
- weakness or heaviness of the legs
Less common
- Bloody urine
- decreased frequency or amount of urine
- increased thirst
- loss of appetite
- lower back or side pain
- swelling of the face, fingers, or lower legs
- weight gain
Rare
- Large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
Other side effects of Entresto
Some side effects of sacubitril / valsartan may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Cough
- dizziness
For Healthcare Professionals
Applies to sacubitril / valsartan: oral pellet, oral tablet.
General
The most common adverse reactions were hypotension, hyperkalemia, cough, dizziness, and renal failure.[Ref]
Cardiovascular
Very common (10% or more): Hypotension (18%)
Common (1% to 10%): Orthostasis[Ref]
Metabolic
Very common (10% or more): Potassium greater than 5.5 mEq/L (16%), hyperkalemia (12%)[Ref]
Renal
Very common (10% or more): Serum creatinine increased greater than 50% (16%)
Common (1% to 10%): Renal failure/acute renal failure[Ref]
Respiratory
Common (1% to 10%): Cough[Ref]
Nervous system
Common (1% to 10%): Dizziness[Ref]
Dermatologic
Uncommon (0.1% to 1%): Angioedema
Postmarketing reports: Rash, pruritus[Ref]
The incidence of angioedema was 2.4% in Black patients.[Ref]
Hematologic
Common (1% to 10%): Hemoglobin/hematocrit decreased greater than 20%[Ref]
Other
Common (1% to 10%): Falls[Ref]
Immunologic
Postmarketing reports: Hypersensitivity, anaphylactic reaction
Frequently asked questions
- Does Entresto improve ejection fraction?
- Which drugs increase ejection fraction?
- What is the normal ejection fraction of the heart?
- How much does Entresto cost per month?
- Can Entresto be cut in half or split?
- How long does it take for Entresto to work?
- Is Entresto a blood thinner and does it lower blood pressure?
- Can you take carvedilol and Entresto at the same time?
More about Entresto (sacubitril / valsartan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (196)
- Drug images
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: angiotensin receptor blockers and neprilysin inhibitors
- En español
Patient resources
Professional resources
Related treatment guides
References
1. (2015) "Product Information. Entresto (sacubitril-valsartan)." Novartis Pharmaceuticals
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.